Exelon

Exelon is formulated to target cognitive decline and is intended to alleviate symptoms of dementia associated with Alzheimer's and Parkinson's.

Strengths: 1.5 · 3mg

Neurology icon Neurology Rivastigmine icon Rivastigmine

Where to Check Availability

Medicine details

Conditions
Therapeutic class

Acetylcholinesterase Inhibitor

Pharmacological class

Acetylcholinesterase Inhibitor

Contraindications

hypersensitivity to rivastigmine; severe hepatic impairment

Minor side effects

nausea; vomiting; dizziness; diarrhoea

Moderate side effects

loss of appetite; weight loss; insomnia; abdominal pain

Dosage forms

Capsule, hard

Administration route

Oral use

Prescription status

POM

Manufacturer

Novartis

Onset Time

2–4 weeks

Duration

8–12 hours

Storage instructions

Store at room temperature below 30°C.

Drug interactions

Metoclopramide; Beta-blockers; Anticholinergic agents

Age restrictions

For adult patients with confirmed diagnosis.

Pregnancy and breastfeeding

Pregnancy: Consult a specialist; data is limited. Breastfeeding: Avoid use.

Precautions and warnings

monitor weight changes; use with caution in patients with history of ulcers; risk of bradycardia; caution in asthma patients

Serious side effects

gastrointestinal ulcer — requires immediate medical attention; bradycardia — requires immediate medical attention; seizures — requires immediate medical attention

Patient summary

Exelon is formulated to target cognitive decline and is intended to alleviate symptoms of dementia associated with Alzheimer's and Parkinson's.

Mechanism of action

Exelon acts as a cholinesterase inhibitor that slows the degradation of acetylcholine, a neurotransmitter essential for memory and cognitive processes, by inhibiting acetylcholinesterase and butyrylcholinesterase enzymes.

Exelon

Exelon is formulated to target cognitive decline and is intended to alleviate symptoms of dementia associated with Alzheimer’s and Parkinson’s.

Editorial Notes

  • Active ingredient(s): Rivastigmine
  • Listed indication(s): Dementia of Alzheimer’s Type, Parkinson’s Disease Dementia

Usually available as

  • 120 tablets - 1.5 mg472-1-5-mg-2927
  • 120 tablets - 3 mg472-3-mg-1086